Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.075x

Based on the latest financial reports, Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a cash flow conversion efficiency ratio of -0.075x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₫-135.66 Billion ≈ $-5.15 Million USD) by net assets (₫1.82 Trillion ≈ $69.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Binh Dinh Pharmaceutical and Medical Equ (DBD) market capitalisation for the company's overall valuation and market capitalisation.

Binh Dinh Pharmaceutical and Medical Equipment JSC - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Binh Dinh Pharmaceutical and Medical Equipment JSC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Binh Dinh Pharmaceutical and Medical Equipment JSC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Binh Dinh Pharmaceutical and Medical Equipment JSC ranked by their cash flow conversion efficiency. Explore Binh Dinh Pharmaceutical and Medical Equ cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Syscom Computer Engineering Co
TW:2453
0.039x
LB Semicon Inc
KQ:061970
0.045x
Bank Bumi Arta Tbk
JK:BNBA
-0.228x
AMIA Co. Ltd.
TW:8438
0.062x
Home Center Holdings Co.Ltd
KQ:060560
0.000x
SHANGH.DAZ.PUBL.UTIL.YC 1
F:6WL
N/A
Fu Yu Property Co Ltd
TWO:4907
0.079x
Duxton Water Ltd
AU:D2O
-0.042x

Annual Cash Flow Conversion Efficiency for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)

The table below shows the annual cash flow conversion efficiency of Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2025. View DBD stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₫1.72 Trillion
≈ $65.40 Million
₫615.19 Billion
≈ $23.37 Million
0.357x +124.27%
2024-12-31 ₫1.66 Trillion
≈ $63.11 Million
₫264.73 Billion
≈ $10.06 Million
0.159x -22.33%
2023-12-31 ₫1.43 Trillion
≈ $54.44 Million
₫293.99 Billion
≈ $11.17 Million
0.205x +68.50%
2022-12-31 ₫1.36 Trillion
≈ $51.49 Million
₫165.01 Billion
≈ $6.27 Million
0.122x +18.13%
2021-12-31 ₫1.14 Trillion
≈ $43.33 Million
₫117.57 Billion
≈ $4.47 Million
0.103x -52.14%
2020-12-31 ₫988.63 Billion
≈ $37.56 Million
₫212.91 Billion
≈ $8.09 Million
0.215x --

About Binh Dinh Pharmaceutical and Medical Equipment JSC

VN:DBD Vietnam Drug Manufacturers - Specialty & Generic
Market Cap
$168.55 Million
₫4.44 Trillion VND
Market Cap Rank
#17271 Global
#99 in Vietnam
Share Price
₫46950.00
Change (1 day)
+1.29%
52-Week Range
₫46000.00 - ₫54400.00
All Time High
₫62000.00
About

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary drugs; analgesic and antipyretic drugs; drugs for muscles, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous … Read more